Nikolaos (Nikos) Papadopoulos is Professor of Allergy and Pediatric Allergy at the University of Athens (NKUA), Greece, and at the University of Manchester, UK. He is also Professor of Allergy, Immunity & Infection at the Observational & Pragmatic Research Institute, Singapore. He has extensive clinical and educational experience, heading a unit that cares for more than 7000 children with allergic diseases yearly, implementing state-of-the-art interventions and training medical students, resident paediatricians, allergists and other healthcare professionals. His research focuses on the interphase between the microbial world and allergic disease, with emphasis in asthma and food allergy.
He has extensive experience in international research projects, such as PreDicta, GA2LEN, EUROPREVALL, iFAAM and FAST, currently co-ordinating the EU “Future and Emerging Technologies” project CURE that explores the role of virome dysbiosis in asthma. Prof Papadopoulos has published over 400 papers (h-index: 86), has received several international awards and is invited to speak at international scientific meetings more than 30 times a year. Moreover, he has/is serving in Boards of EAACI, GA2LEN, WAO, EFA and ARIA. He was the 2013-2015 President of EAACI and the 2017-2019 President of the Respiratory Effectiveness Group (REG). He is the Editor-in-Chief of “Frontiers in Allergy”.
